Secretory Cells: New Players in Small Airway Mucosal Immunity?

Umadevi Sajjan
DOI: https://doi.org/10.1165/rcmb.2022-0210ED
IF: 7.748
2022-09-02
American Journal of Respiratory Cell and Molecular Biology
Abstract:The epithelium lining of the conducting airways plays a pivotal role in protecting the lungs from environmental insults and shaping the innate and adaptive immunity in the lungs. Patients with chronic obstructive pulmonary disease (COPD) often exhibit structural changes in the airway epithelium (1), which can affect its innate immune function, including its secretion of IgA. On the basis of the role of secretory IgA (SIgA) in gut mucosal immunity, it is speculated that SIgA may play a similar role in the airways, which are constantly bombarded with airborne pathogens. The data regarding SIgA in COPD airway fluid is controversial, with one study showing reduction (2), a second demonstrating no difference between normal and COPD (3), and a third reporting higher concentrations of SIgA in smokers and patients with COPD with mild to moderate disease (4). However, there appears to be variability in the concentrations of SIgA within the same patient on the basis of the airway remodeling that can range from normal-appearing to goblet cell hyperplasia, basal cell metaplasia, incompletely differentiated areas, and squamous metaplasia (2). SIgA was more abundant in normal-appearing than in remodeled zones, indicating a localized loss of SIgA. Importantly, loss of SIgA in small airways correlated with severe airway obstruction in COPD (5). Furthermore, mice lacking SIgA developed spontaneous COPD-like lung disease and showed the presence of bacteria in the affected airways (6).
biochemistry & molecular biology,cell biology,respiratory system
What problem does this paper attempt to address?